The Changing Landscape of Conflict of Interest Supports Further Study of American Society of Clinical Oncology Authorship Restrictions for

As a leading source of cancer information worldwide, the American Society of Clinical Oncology (ASCO) values the trust of its members, the oncology community, and the public. ASCO has long been committed to transparency and independence in finan-cial interactions with health care companies. For nearly two de-cades, ASCO has had policies in place that require disclosure of financial relationships by authors, presenters, and member volun-teers. ASCO uses the information to manage and minimize the potential for bias and maintain the objective voice of its journals, Continuing Medical Education, clinical practice guidelines, and quality improvement programs. The most recent revision to the ASCO conflict of interest (COI) policy was published online in Journal of Clinical Oncology on April 22, 2013, and will be imple-mented later this year.1 This updated policy, as explained in an accompanying article on background and rationale,2 again empha